By Kimberly Chin

Alexion Pharmaceuticals Inc. (ALXN) said it has named Aradhana Sarin as its next chief financial officer, succeeding CFO Paul Clancy later this year.

Ms. Sarin is currently Alexion's chief strategy and business officer. She joined the company in November 2017.

The transition will take place after the company reports its third-quarter financial results, Alexion said.

Mr. Clancy will assist Ms. Sarin with the transition, Alexion said. Mr. Clancy is expected to stay on as a senior adviser until mid-2020.

"I believe Alexion has great potential and the ability to achieve its strategic vision, and I will work with the entire team to ensure a seamless transition," Mr. Clancy said in prepared remarks.

Shares slipped 1.7% in after-hours trading to $106.01.

Write to Kimberly Chin at kimberly.chin@wsj.com

(END) Dow Jones Newswires

September 17, 2019 16:45 ET (20:45 GMT)

Copyright (c) 2019 Dow Jones & Company, Inc.
Alexion Pharmaceuticals (NASDAQ:ALXN)
Historical Stock Chart
From Mar 2024 to Apr 2024 Click Here for more Alexion Pharmaceuticals Charts.
Alexion Pharmaceuticals (NASDAQ:ALXN)
Historical Stock Chart
From Apr 2023 to Apr 2024 Click Here for more Alexion Pharmaceuticals Charts.